Recent Approvals in Vaccination Against SARS-CoV-2 and the Omicron Subvariants - Episode 4

COVID-19 Booster Vaccination Protection Rates

Published on: November 11, 2022

Rodney Rohde, SV, SM, MB (ASCP), FACSc, Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, Jacinda Abdul-Mutakabbir, PharmD, Madeline King, PharmD, BCIDP

Jacinda Abdul-Mutakabbir, PharmD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; and Madeline King, PharmD, BCIDP, examine the efficacy and real-world implications of the COVID-19 booster shot in terms of vaccination protection rates.

EP. 1: Overview of SARS-CoV-2 Virus and Subvariants

EP. 2: Defining Variants of Interest vs Variants of Concern

EP. 3: Impact of SARS-CoV-2 Subvariants on Vaccination

Now Viewing

EP. 4: COVID-19 Booster Vaccination Protection Rates

EP. 5: Evolution of SARS-CoV-2 Variants on Booster Shot Development and Formulations

EP. 6: Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination

EP. 7: CDC and FDA Recommendations for SARS-CoV-2 Booster Shots

EP. 8: Influenza Vaccination With SARS-CoV-2 mRNA Booster Shots

EP. 9: Long-Term Data on SARS-CoV-2 Booster Shots

EP. 10: Initiating Patient Conversations Around SARS-CoV-2 Booster Shots

EP. 11: Safety of SARS-CoV-2 Bivalent Booster Shots

EP. 12: Impact of COVID-19 Pandemic on Antimicrobial Resistance

EP. 13: Addressing Vaccine Hesitancy and Uptake for SARS-CoV-2